how to s.e.a.r.c.h.™ for the ms g · 3/11/2016 · ms neurologist cleveland clinic lou ruvo...
TRANSCRIPT
HowtoS.E.A.R.C.H.™forthe
RightMSTherapyforYou!
G
LiveWebinar
October19,2016
presents
HowtoS.E.A.R.C.H.
™
forthe RightMSTherapyforYou!
GuestPresenter
CarrieM.Hersh,DO,MS
MSNeurologist
ClevelandClinicLouRuvoCenterforBrainHealth
LasVegas,NV
Acknowledgements
MSAAwouldliketotakethisopportunitytothankthesupportersofthisprogram.
Thiswebinar,alongwiththerecentlyrevisedS.E.A.R.C.H.™bookletandpatientworkbook,havebeenmadepossiblewiththesupportofEMDSeronoandSanofiGenzyme.
MSAAissolelyresponsibleforthedevelopmentofS.E.A.R.C.H.™anditscontent.
Programs and Services
Providing Information . . .
• Toll-free Helpline at (800) 532-7667 • Online response forums via Chat feature and email option at [email protected] • Free mobile phone application - My MS Manager™
Easing Daily Life . . . • Equipment distribution • Cooling program • MRI Access Fund
Finding Answers . . .
• Comprehensive website: mymsaa.org
• Award-winning publications, videos, and webinars
• S.E.A.R.C.H.™ initiative
Staying Connected . . .
• In-person educational events
• New online peer community – My MSAA Community
•Social media presence via Facebook, Twitter, YouTube, etc.
HowtoS.E.A.R.C.H.™fortheRightMSTherapyforYou!WebinarObjectives
• ExplorethechanginglandscapeofMS,lookingatcurrentandfuturetreatments
• Emphasizetheimportanceoftreatmentadherenceandcompliance
• Lookattoday’sdoctor-patientrelationshipandhowbothsidescanworktogether
• LearnaboutMSAA’sS.E.A.R.C.H.™program–whichcanhelpyourdecisiontochoosetherightMStherapyforYOU!!!
TheChangingLandscapeofMS
Priorto1993,theMSlandscapelookedfairlybarren
• TherewerenoFDA-approvedtreatmentsforMS
• Limitedapproachtotreatingsymptomsandmanagingthedisease
• Noconsistentuseofrehabilitationservices
TheChangingLandscapeofMS
Becauseofsuchlimitedoptionsatthetime,adviceto
manyMSpatientsincludedstatementssuchas...
• Gohomeandrest–trynottodotoomuch
• Don’tgetexposedtotheheat
• Youmaywanttoconsidernothavingchildren
TheChangingLandscapeofMS
Since1993,thisbarrendeserthasbeentransformedintoafertile,growinglandscapeflourishingwith...
• MorethanadozenFDA-approvedtreatmentsforMSwithmoreunderdevelopment
• Amorecomprehensiveapproachtotreatingandmanagingthedisease,withanincreasedfocusonrehabilitationandwellness
TheChangingLandscapeofMS
CurrentFDA-ApprovedMSDiseaseModifyingTherapies(DMTs)
Self-InjectedMedications InfusedMedications OralMedications
Avonex® Lemtrada® Aubagio®
Betaseron® Novantrone® Gilenya®
Copaxone® Tysabri® Tecfidera®
Extavia®
Glatopa®
Plegridy®
Rebif®
Zinbryta®
TheChangingLandscapeofMS
NewLong-TermTreatmentsontheHorizon
Ocrelizumab-ahumanizedmonoclonalantibodythatfunctionssimilarlytoanothertherapycommonlyusedforautoimmuneconditions,Rituximab
-FirstdiseasemodifyingtherapyofitskindtodemonstratepositivebenefitinpatientswithprimaryprogressiveMS-Administeredviaintravenousinfusionevery6months-ClinicaltrialsshowedexcellentreductionofclinicalrelapsesandnewMRIlesionscomparedtoastandardinjectableMStherapy-Expectedtobeavailableforcommercialusein2017
TheChangingLandscapeofMS
NewLong-TermTreatmentsontheHorizon
Siponimod-anoraltreatmentstrategywithsimilarstructureandfunctionasfingolimod
-PotentialtreatmentoptionforpatientswithsecondaryprogressiveMS
-RecentlyannouncedatECTRIMS2016inLondon,EnglandtodemonstratepositivebenefitindelayingdisabilityprogressioninpatientswithsecondaryprogressiveMSinaphase3clinicaltrialcomparedwithplacebo
TheChangingLandscapeofMS
NewLong-TermTreatmentsontheHorizon
Ofatumumab-afullyhumanmonoclonalantibodythatfunctionssimilarlytoRituximabandOcrelizumab
-Expectedtobewelltoleratedgivenitshumanstructure
-Inphase2clinicaltrials,OfatumumabdemonstratedsignificantreductioninnumberofrelapsesandnewMRIlesions,andnounexpectedsafetyfindingswerereported
-Ofatumumab,administeredasaoncemonthlyinjectionunderneaththeskin,isenteringaphase3clinicaltrialthatwillbeinvestigatingitsefficacyandsafetyinalargerpopulationofpatientswithrelapsingformsofMS
ImportanceofAdherence
SIMPLEFACT:
ResearchhasproventhatmostMSpatientswith
relapsingformsofMSwhostartandcontinueusinga
DMTtreatmentaccumulatelessdisabilityovertime,
andataslowerratethanpatientswhoare
non-compliant.
HavingaGoodDoctor-PatientRelationship
“Yourappointmentwiththedoctorisat
11:15,buthisappointmentwithyouis
at12:15.”
“Giveittomestraight,Doc.HowlongdoIhavetoignoreyouradvice?”
The Cartoon Bank/Condé Nast Publications Inc.
HavingaGoodDoctor-PatientRelationship
• GiventhecomplexityofMS,thedoctorandpatientmustworktogethertounderstandtheproblemsandfindsuccessfulsolutions
• Establishingopenandhonestdoctor-patientcommunicationwillhelpfoster: -mutualtrust
-enhancedaccuracyofdiagnosisandtreatment
-improvedadherenceandcompliance
-increasedpatientsatisfaction,reducedcomplaints
-thebestpossiblehealthandoverallqualityoflife
WaystoHelp
• Beproactiveandtakechargeofyourhealthcare -UsecredibleInternetsitestoresearchinformation -KeepajournaloruseMSAA’smobilephoneapp
(MyMSManager™) -Maintainotherhealthcareneedsandappointments
• Understandthereducedtimedoctorshavetospendwiththeirpatientsandcomeprepared
• UseMSAA’sS.E.A.R.C.H.™modeltodiscussyourMStreatmentoptionsandmakeaninformeddecision
WhatisS.E.A.R.C.H.™
MSAA’sS.E.A.R.C.H.™
• Aneasyacronymthathelpsyouremember,organize,andprioritizeimportantquestionstodiscusswithyourdoctororhealthcareteam
• Eachletterrepresentskeyareasthatneedtobeconsideredwhen“searching”forthemostappropriateMStreatment
S.E.A.R.C.H.™standsfor:
SAFETYEFFECTIVENESSACCESSRISKSCONVENIENCEHEALTHOUTCOMES(overallwellnessandqualityoflife)
MSAA’sS.E.A.R.C.H.™
Safety
SuggestedQuestions:
SpecifictotheMStherapiesyouareconsidering...
• Whatarethelong-termsafetyprofilesoftheseFDA-approvedDMTs?
• WhattestsarerequiredpriortotakingorwhilereceivingcertainDMTs?
• HowwillDMTsinteractwithmycurrentmedicaltreatments,othermedicalconditions,andanycomplementaryandalternativemedicines?
• WhataretheconcernsaboutpregnancyorbreastfeedingwhiletakingoneoftheseDMTs?
MSAA’sS.E.A.R.C.H.™
Effectiveness
SuggestedQuestions:
SpecifictotheMStherapiesyouareconsidering...
• HoweffectivearetheseDMTsinreducingMSrelapses,disability,andMRIactivity?
• WhataremyrealisticexpectationsregardingtheeffectivenessoftheseDMTs?
• HowcanItellifmyDMTisworking?
• WhenshouldIconsiderusingadifferentDMT?
MSAA’sS.E.A.R.C.H.™
Access
AccesstoDMTsandtheabilitytoswitchtherapiescanvary
greatlydependingonyourinsuranceprovider,coveragelevelsand
otherrestrictions.MSAAhasacomprehensivewebsitesectiontitled,
MyHealthInsuranceGuide,tohelppeoplebetterunderstandandutilizetheirhealthinsurance.
SuggestedQuestions:SpecifictotheMStherapiesyouareconsidering...
• WhichDMTsarecoveredbymyinsurancecarrier?
• WhataretheirTierLevelsandhowdoesthataffectcost?
• Arethereassistanceprogramsthroughthepharmaceuticalcompanies,governmentorcharities?
MSAA’sS.E.A.R.C.H.™
Risk
SuggestedQuestions:
SpecifictotheMStherapiesyouareconsidering...
• WhataretherisksofsideeffectswiththeseDMTs?
• Howfrequentandseverearethesideeffects?• Howsoondotheysubside?
• Canthesesideeffectsbemanaged?
• Howdoyoubalancetherisks?
MSAA’sS.E.A.R.C.H.™
Convenience
SuggestedQuestions:
SpecifictotheMStherapiesyouareconsidering...
• HowaretheDMTsadministered?
• HowoftendoItaketheseDMTs?
• MustIhaveregulartestsorvisitstootherhealthcareproviderstomonitortheeffectsofmytreatment?
MSAA’sS.E.A.R.C.H.™
HealthOutcomes
SuggestedQuestions:
SpecifictotheMStherapiesyouareconsidering...
• HowwillmygeneralhealthandqualityoflifebeaffectedbytheseDMTs?
• WhatwillmyMSlooklikeinfiveor10years?
• WilltakingaDMTlowermyimmunesystemandcauseotherproblems?
• CantheseDMTsassistwithmymobility,cognition,andotherhealthfactors?
S.E.A.R.C.H.™Tools
MSAAhasproducedavarietyofinformationaltoolstohelpmaximizeyoursuccesswith
S.E.A.R.C.H.™Currenttoolsavailableatmymsaa.orginclude:
• S.E.A.R.C.H.™BookletwithlaminatedReferenceCard
• S.E.A.R.C.H.™PatientWorkbooktowritenotesandorganizequestionsforthedoctor
• MSDiseaseModifyingTherapyChartofcurrentlyapprovedtreatments
• MSResourceGuidelistingMSorganizationsandpharmaceuticalassistanceprograms
• mymsaa.org/healthinsurancewithinformationontheAffordableCareActandMedicare
RemainingAdherent
• OnceaDMTisinitiated,evidencesuggests
thattreatmentneedstobeongoingforbenefits
topersist.Non-adherenceandgapsintreatment
havebeenassociatedwithanincreasedrateof
relapsesandprogressionindisability.
• Understandably,adherencecanpresentcertain
challengesovertime.Fortunatelymanyofthesechallengescanbemanagedto
keeppeopleoncourse.
RemainingAdherent
SomeHelpfulStrategiestoHelpBuildTowardOngoingTreatmentAdherenceinclude:
• ManagingSideEffects -Takeover-the-countermedicationstomanagetemporaryflu-like symptoms;ice-downandrotateinjectionsites;useanautoinjector
• UnderstandingExpectations -Discussrealisticexpectationswithyourdoctor;givetheDMT1yr.to haveaneffect;realizeifyoudon’t“see”resultsthenitmightbeworking
• LearningtoAdjust -Setascheduleandusecalendarremindersorstickynotestohelpremembertotakeyour medication;receivepropertrainingifneededonself-injectiontechniques; ifproblemsarise,don’tjuststoptakingyourDMT–talktoyourdoctor!
ToSummarize
Take-homemessages:
• ViewMSasanever-changinglandscapethatholdsgreatpromiseforthefuture
• RecognizethatbeingadherenttoanMSDMTwillhelpreduceattacksandlessendisabilityovertime
• Beproactiveinmanagingyourhealthcare
• Strivetohaveagooddoctor-patientrelationship
• UseS.E.A.R.C.H.™tohelpdiscussMSmedicationswithyourdoctorandselectthetherapythatisrightforYOU!
ThankYou
ThisconcludesMSAA’sWebinar:
HowtoS.E.A.R.C.H.™fortheRightMSTherapyforYou!
ThiswebinarwillbeavailablesoononMSAA’swebsite:www.mymsaa.org
MSAAwouldliketothankDr.Hershforherexcellentpresentationon
multiplesclerosisandtheS.E.A.R.C.H.™initiative,aswellassupportersEMDSeronoandSanofiGenzyme.
ThankyouforparticipatinginMSAA’swebinar.